CDKN2 mutation is infrequent in german hepatocellular carcinoma

Citation
M. Volkmann et al., CDKN2 mutation is infrequent in german hepatocellular carcinoma, ONCOL-BASEL, 57(4), 1999, pp. 306-310
Citations number
27
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
ONCOLOGY
ISSN journal
00302414 → ACNP
Volume
57
Issue
4
Year of publication
1999
Pages
306 - 310
Database
ISI
SICI code
0030-2414(1999)57:4<306:CMIIIG>2.0.ZU;2-Q
Abstract
For hepatocellular carcinoma, only scarce and controversial data on CDKN2 a lterations are available. A high rate of mutations in a Chinese study contr asts with a low rate found in Japanese tumors and a CDKN2 germline mutation in 4/26 Swiss tumors examined. We analyzed 23 hepatocellular carcinomas fr om German patients for homozygous deletions of CDKN2 by coamplification wit h the human tyrosine hydroxylase (TH) gene and for CDKN2 mutations by PCR-s ingle strand conformation polymorphism analysis and direct DNA sequencing. Our results indicate the lack of homozygous deletions. In one tumor, DNA se quencing showed a GCG-ACG (alanine-threonine) substitution at codon 148, a polymorphism in exon 2 of CDKN2. We conclude that the alteration of CDKN2 b y deletion or mutation appears not to be a frequent event in hepatocarcinog enesis in German patients. Copyright (C) 1999 S. Karger AG, Basel.